相关实验视频

Updated: Jul 3, 2026

VIGS-Mediated Forward Genetics Screening for Identification of Genes Involved in Nonhost Resistance

VIGS-Mediated Forward Genetics Screening for Identification of Genes Involved in Nonhost Resistance

Published on: August 23, 2013

鉴定新型候选基因,用于阿斯科奇塔 (Ascochyta) 杂草病菌在小豆中的耐药性

Françoise Dalprá Dariva¹, Amlan Arman², Mario Morales¹

¹Department of Plant Sciences, North Dakota State University, Fargo, ND, 58102, USA.

Scientific reports

|December 29, 2024

概括

研究人员在豆中发现了Ascochyta病耐药性的新遗传标记. 这些发现可以帮助开发耐药品种,减少在小豆生产中使用杀菌剂的需求.

科学领域:

植物病理学植物病理学
遗传学是一个遗传学.
农业科学农业科学

背景情况:

由Ascochyta rabiei引起的Ascochyta 虫害严重影响了全球小豆生产.
开发具有广泛耐药性的豆品种对美国北大平原至关重要.

研究的目的:

在小中发现新型遗传变异的阿斯科奇塔虫害耐药性.
为了确定与耐药性相关的定量特征核酸 (QTNs).

主要方法:

全基因组关联研究 (GWA) 对219个小豆系进行了研究.
在疫苗注射后的多个时间点对阿斯科奇塔虫耐药性的评估.
使用多个GWA模型进行分析以识别QTN.

主要成果:

在染色体1,3,4,6和7上发现了8个QTN.
在Chr3上的一种QTN解释了33%的疾病严重程度变化,这与含有基因的基因重复相关.
在QTN区域附近发现了153个参与植物防御机制的候选基因.

结论:

这项研究确定了与阿斯科奇塔病耐药性相关的显著遗传基因位点.
已识别的QTN和候选基因为培育耐药小豆品种提供了宝贵的资源.
进一步的研究可以减少杀菌剂的使用,提高豆产量.

关键词:

听到了拉比的声音.疾病耐药性疾病耐药性全基因组关联研究研究.豆类作物豆类作物豆类作物

更多相关视频

Tomato Root Transformation Followed by Inoculation with Ralstonia Solanacearum for Straightforward Genetic Analysis of Bacterial Wilt Disease

Tomato Root Transformation Followed by Inoculation with Ralstonia Solanacearum for Straightforward Genetic Analysis of Bacterial Wilt Disease

Published on: March 11, 2020

Dry Root Rot Disease Assays in Chickpea: a Detailed Methodology

Dry Root Rot Disease Assays in Chickpea: a Detailed Methodology

Published on: January 17, 2021

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...